MIRAI Therapeutics

Mirai Therapeutics is a biotechnology company dedicated to revolutionizing targeted therapy through precision drug delivery. Its mission is to enhance the performance of nanoparticle-based drug delivery systems, providing pharmaceutical industries and research centers with safer and more effective treatments. A key innovation is their nanocoating formulation, designed to improve the safety and efficiency of drug-loaded nanocarriers by ensuring they remain intact during delivery. This approach aims to significantly reduce thrombo-inflammation, a common challenge in drug delivery, by over 60%. Mirai Therapeutics adheres to ISO 10993 standards for safety and compatibility testing, offering comprehensive reports and expert consultation to guide clients in interpreting test results.